TrialJournal of the American Medical Directors Association2018

A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.

Guillermo E Umpierrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.